Prevalence of Myocardial Scars on CMR After COVID-19 Infection

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

Also called NCT04636320

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 231 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04636320
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04636320. Non-randomized; no masking; primary purpose diagnostic. Start 2020-06-13 (actual); primary completion 2022-04-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevalence of Myocardial Scars on CMR After COVID-19 Infection
Acronym
COVID-CMR
Condition
COVID-19
Condition
Virus Disease
Intervention (Device)
Contrast-enhanced CMR
Intervention (Diagnostic test)
Exercise test ECG (electrocardiogram)
Intervention (Biological)
Blood sample
Intervention (Diagnostic test)
Resting 12 lead ECG
Intervention (Diagnostic test)
24 hour Holter ECG
Lead sponsor
University Hospital, Bordeaux (class: other)
Collaborator
Grant Agreement ERC n°715093 (class: not stated)
Collaborator
University of Bordeaux (class: other)

Record details

Record id
cardio:ct-nct04636320
Content hash
c2d276d8a5d99436b5c7b1d8d2233ac7724d6d62f248781e05771f5db46394d3